Newer recombinant alternatives to the horseshoe crab-derived LAL are also available and are increasingly used by progressive pharmacies
GLP-1 receptor agonists are FDA-approved therapies for T2DM, and recent studies have explored their potential as repurposed treatments for neurodegenerative diseases, including PD, AD, and ALS, as well as cerebrovascular disorders
The mechanism of action may involve reducing the number of activated lymphocytes in the central nervous system that cause multiple sclerosis
To mitigate liver damage caused by tumor drugs, chemotherapeutic agents are often combined with GSH, effectively reducing their toxic side effects and protecting the patients liver
Interestingly, some tirzepatide studies actually showed hair regrowth in certain cases, which suggests the relationship between these medications and hair is more complex than simple shedding
320 , G837g846 (2021)